Surgical biopsy

What it is

Surgical biopsy is a procedure in which a surgeon makes an incision to remove part or all of an abnormal area for laboratory diagnosis. The key practical point is that it may remove either only a sample of tissue, called an incisional biopsy, or the entire lesion, called an excisional biopsy.

A biopsy is often the only way to confirm whether a suspicious lump, ulcer, lymph node, or internal lesion is cancer, infection, inflammation, or another condition. In a surgical biopsy, the doctor reaches the abnormal area through a cut in the skin or mucosa rather than with a needle alone. This is why it is also called an open surgical biopsy.

Surgical biopsy is usually considered when a needle biopsy is not possible, has not given a clear answer, or when removing the whole lesion is both feasible and useful. Depending on the site, it may be done under local anesthesia, sedation, regional anesthesia, or general anesthesia. The removed tissue is sent to a pathology laboratory, where it is examined under a microscope and may also undergo special tests such as immunohistochemistry or molecular testing.

A simple way to think about the main forms is:

Type	What is removed	Common purpose
Incisional biopsy	Part of the abnormal tissue	Diagnosis when the lesion is large or in a difficult location
Excisional biopsy	The whole lesion, often with a small margin	Diagnosis and sometimes complete removal of a small lesion

In cancer care, the goal is not just to say whether cancer is present, but also to identify the cancer type, grade, and sometimes biomarkers that guide treatment.

How it works

The procedure starts with locating the suspicious area by physical examination, imaging, or both. The surgeon then cleans the area, gives anesthesia, and makes an incision to expose the lesion. A piece of tissue or the whole lesion is removed with instruments designed to preserve tissue architecture, which helps the pathologist interpret the sample.

This matters because tissue architecture can be important for diagnosis. Compared with fine-needle aspiration, surgical biopsy usually provides a larger specimen and more surrounding context, which can improve diagnostic certainty in some situations. It may be especially useful when the diagnosis depends on seeing how cells are arranged within the tissue, not just what individual cells look like.

After removal, the specimen is placed in the correct container and sent to pathology. The pathologist may perform:

1. Routine histopathology
2. Special stains for infection or tissue type
3. Immunohistochemistry to classify tumours
4. Molecular or genetic tests when needed

If the biopsy is done for a small skin lesion or superficial lump, the wound may be closed with stitches and covered with a dressing. For deeper procedures, closure can be more complex and may sometimes require drains.

Evidence and uses

Surgical biopsy remains a standard diagnostic procedure across many specialties, but in many settings it has been partly replaced by less invasive needle techniques when those can provide enough tissue. For example, in breast, lymph node, soft tissue, and some organ lesions, core needle biopsy is often preferred first because it is less invasive and usually has a shorter recovery time. Still, open surgical biopsy remains important when less invasive tests are nondiagnostic or technically difficult.

Common reasons a clinician may recommend surgical biopsy include:

• A needle biopsy did not give a clear diagnosis
• The lesion is small enough to remove completely
• The location or structure makes needle sampling unreliable
• More tissue is needed for accurate classification
• There is concern for conditions where tissue architecture is essential, such as some lymphomas or soft tissue tumours

In breast diagnosis, evidence reviews have compared core needle biopsy with open surgical biopsy and generally support needle biopsy as the first step when appropriate. However, open biopsy may still be needed in selected cases. In soft tissue and bone tumours, the biopsy approach must be planned carefully because a poorly placed incision can complicate later surgery.

For patients in India, the same principles apply in tertiary cancer centres and surgical units: the best biopsy is the one that gets enough representative tissue safely, without making later treatment harder. In suspected cancer, biopsy planning is often coordinated with the surgeon, radiologist, and pathologist so that the first procedure is also the right one.

Diagnosis / how it's measured

A surgical biopsy does not itself diagnose the condition until the tissue is examined in the laboratory. The pathology report is the main result. Depending on the disease being investigated, the report may include:

• Whether the tissue is benign, precancerous, or malignant
• The exact tumour or disease type
• Grade or aggressiveness
• Margin status if the whole lesion was removed
• Presence of infection, granulomas, necrosis, or inflammation
• Receptor or biomarker results, if ordered

Turnaround time varies by hospital and by the tests needed. A basic histopathology result may come in a few days, while immunohistochemistry or molecular studies can take longer.

Before the procedure, clinicians may review blood tests, medicines, and imaging. If you take blood thinners, antiplatelet drugs, or have a bleeding disorder, the team may need to adjust the plan. This should only be done under medical advice.

When to see a clinician

You may need evaluation for biopsy if you have a persistent lump, nonhealing ulcer, enlarged lymph node, unexplained mass on imaging, or tissue change that your doctor cannot identify confidently by examination alone. A biopsy is also considered when symptoms or scans raise concern for cancer recurrence.

After a surgical biopsy, contact your clinician promptly if you develop:

• Increasing redness, swelling, or pus at the wound
• Fever
• Bleeding that does not stop with pressure
• Severe pain not controlled by prescribed medicines
• Wound opening or foul-smelling discharge

If the biopsy was from the breast, neck, mouth, or another sensitive area, ask specifically about expected swelling, dressing care, bathing, and when stitches will be removed.

Limitations and open questions

Surgical biopsy is highly useful, but it is not perfect. Even an open biopsy can miss the most representative area if the lesion is heterogeneous, infected, necrotic, or difficult to access. In some cancers, a second biopsy may still be needed if the sample is inadequate for modern biomarker testing.

The main trade-off is that surgical biopsy is more invasive than needle biopsy. It usually involves a larger wound, more recovery time, and a higher chance of bleeding, infection, scarring, or anesthesia-related complications. For this reason, clinicians often prefer less invasive methods first when they are likely to answer the question.

Another limitation is that biopsy planning matters. In sarcomas and some other tumours, the incision should be placed so it can be removed during definitive surgery if cancer is confirmed. This is one reason patients with suspected complex tumours are often referred to specialist centres before biopsy.

Evidence strongly supports biopsy as the basis of diagnosis, but the best biopsy method depends on the organ, suspected disease, imaging findings, and local expertise. If your report is unclear, it is reasonable to ask whether the sample was adequate, whether more tests are pending, and whether review by an experienced pathologist is needed.